Prosecution Insights
Last updated: April 19, 2026
Application No. 18/936,921

Presenting Therapy Events on a Continuous, Time-Based Data Feed

Non-Final OA §112§DP
Filed
Nov 04, 2024
Examiner
PAULS, JOHN A
Art Unit
3683
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Tandem Diabetes Care Inc.
OA Round
1 (Non-Final)
49%
Grant Probability
Moderate
1-2
OA Rounds
3y 9m
To Grant
76%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allow Rate
404 granted / 829 resolved
-3.3% vs TC avg
Strong +28% interview lift
Without
With
+27.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
46 currently pending
Career history
875
Total Applications
across all art units

Statute-Specific Performance

§101
28.8%
-11.2% vs TC avg
§103
33.4%
-6.6% vs TC avg
§102
11.3%
-28.7% vs TC avg
§112
20.9%
-19.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 829 resolved cases

Office Action

§112 §DP
DETAILED ACTION Status of Claims This action is in reply to the application filed on 4 November, 2024. Claims 1 - 20 are currently pending and have been examined. The present application is a continuation of U.S. Application Number 17/517,885 now U.S. Patent Number 12,136,479 B2. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claims 1 – 20 are rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor regards as the invention. Claims 1, 11 and 20 recite displaying a trend line that depicts “the glucose level data for the predetermined time frame”. Initially, Examiner asserts that there is no antecedent for the terms “the glucose level data”. The method receives “glucose data indicative of a glucose level of a user”; which may reasonably be construed as a single glucose measurement taken at a particular point in time. (The parent application recites “receiving glucose level data of a user”; which does not limit the data to “a glucose level”. Examiner cannot determine how to display a trend line for a single measurement. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP §§ 706.02(l)(1) - 706.02(l)(3) for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 1 - 20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1, 4, 5, 7, 8, 15, 18 and 19 of U.S. Patent No. 12,136,479 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the issued claims recite all of the limitations of the pending claims with only minor variations. The table below lists the correspondence of the pending claims to the issued claims in the patent above: Pending Claims Issued Claims 1/11/20 1 2/12 1 3/13 4 4/14 1 5/15 5 6/16 8 7/17 7 8/18 18 9/18 19 10/19 15 The implementation of the method on a conventional mobile device using software instructions are obvious modifications to the method alone. With respect to Claims 2/12 and 4/14, Examiner asserts that plurality of events” recited in issued claim 1 is equivalent to the “additional icons” received and displayed. CONCLUSION Any inquiry of a general nature or relating to the status of this application or concerning this communication or earlier communications from the Examiner should be directed to John A. Pauls whose telephone number is (571) 270-5557. The Examiner can normally be reached on Mon. - Fri. 8:00 - 5:00 Eastern. If attempts to reach the examiner by telephone are unsuccessful, the Examiner’s supervisor, Robert Morgan can be reached at (571) 272-6773. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://portal.uspto.gov/external/portal/pair. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866.217.9197. Official replies to this Office action may now be submitted electronically by registered users of the EFS-Web system. Information on EFS-Web tools is available on the Internet at: http://www.uspto.gov/patents/process/file/efs/guidance/index.jsp. An EFS-Web Quick-Start Guide is available at: http://www.uspto.gov/ebc/portal/efs/quick-start.pdf. Alternatively, official replies to this Office action may still be submitted by any one of fax, mail, or hand delivery. Faxed replies should be directed to the central fax at (571) 273-8300. Mailed replies should be addressed to “Commissioner for Patents, PO Box 1450, Alexandria, VA 22313-1450.” Hand delivered replies should be delivered to the “Customer Service Window, Randolph Building, 401 Dulany Street, Alexandria, VA 22314.” /JOHN A PAULS/Primary Examiner, Art Unit 3683 Date: 12 January, 2026
Read full office action

Prosecution Timeline

Nov 04, 2024
Application Filed
Jan 12, 2026
Non-Final Rejection — §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12586676
IMAGE INTERPRETATION MODEL DEVELOPMENT
2y 5m to grant Granted Mar 24, 2026
Patent 12586668
System and Method for Patient Care Improvement
2y 5m to grant Granted Mar 24, 2026
Patent 12567483
AUTOMATED LABELING OF USER SENSOR DATA
2y 5m to grant Granted Mar 03, 2026
Patent 12548670
EMERGENCY MANAGEMENT SYSTEM
2y 5m to grant Granted Feb 10, 2026
Patent 12548664
ADAPTIVE CONTROL OF MEDICAL DEVICES BASED ON CLINICIAN INTERACTIONS
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
49%
Grant Probability
76%
With Interview (+27.5%)
3y 9m
Median Time to Grant
Low
PTA Risk
Based on 829 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month